Nielsen, M. A., Køster, D.
, Stengaard-Pedersen, K., Busson, P., Junker, P., Hørslev-Petersen, K., Hetland, M. L., Østergaard, M.
, Hvid, M., Kragstrup, T. W. & Deleuran, B. (2022).
POS0415 PLASMA GALECTIN-9 IS ASSOCIATED WITH CLINICAL DISEASE ACTIVITY IN TREATMENT NAÏVE EARLY RHEUMATOID ARTHRITIS, UNAFFECTED BY DMARD TREATMENT, AND IN VITRO MODULATES THE SECRETION OF MCP-1 AND IL-6 IN RHEUMATOID ARTHRITIS SYNOVIAL FIBROBLASTS.
Annals of the Rheumatic Diseases,
81(Suppl 1), 462-463.
https://doi.org/10.1136/annrheumdis-2022-eular.1213
Noer, J. B.
, Hørsdal, O. K., Xiang, X., Luo, Y. & Regenberg, B. (2022).
Extrachromosomal circular DNA in cancer: history, current knowledge, and methods.
Trends in Genetics,
38(7), 766-781.
https://doi.org/10.1016/j.tig.2022.02.007Nordenskjöld, A. M., Johansson, N., Sunnefeldt, E., Athlin, S.
& Fröbert, O. (2022).
Prevalence and prognostic implications of myocardial injury in patients with influenza.
European Heart Journal Open,
2(5), Article oeac051.
https://doi.org/10.1093/ehjopen/oeac051Nudel, R., Thompson, W. K.
, Børglum, A. D., Hougaard, D. M.
, Mortensen, P. B., Werge, T., Nordentoft, M. & Benros, M. E. (2022).
Maternal pregnancy-related infections and autism spectrum disorder-the genetic perspective.
Translational Psychiatry,
12, Article 334.
https://doi.org/10.1038/s41398-022-02068-9Olesen, A. E., Schacksen, C. S., Nielsen, I. M.
, Nielsen, L. P., Andersen, S.
& Andersen, C. U. (2022).
Significantly higher use of polypharmacy in elderly with hip fracture treated with psychotropics.
Danish Medical Journal,
69(10), Article A12210945.
Ostenfeld, A., Petersen, T. S.
, Pedersen, L. H., Westergaard, H. B., Løkkegaard, E. C. & Andersen, J. T. (2022).
Mirtazapine exposure in pregnancy and fetal safety: A nationwide cohort study.
Acta Psychiatrica Scandinavica,
145(6), 557-567.
https://doi.org/10.1111/acps.13431Palarasah, Y., Henriksen, A. S. L.
, Thiel, S., Henriksen, M. & Hansen, S. W. K. (2022).
Potency measurements of the complement system facilitated by antibodies targeting the zymogen form of complement factor D (Adipsin).
Molecular immunology,
146, 46-49.
https://doi.org/10.1016/j.molimm.2022.04.002Pálovics, R., Keller, A., Schaum, N., Tan, W., Fehlmann, T., Borja, M., Kern, F., Bonanno, L., Calcuttawala, K., Webber, J., McGeever, A., Tabula Muris Consortium, Luo, J., Pisco, A. O., Karkanias, J., Neff, N. F., Darmanis, S., Quake, S. R. & Wyss-Coray, T. (2022).
Molecular hallmarks of heterochronic parabiosis at single-cell resolution.
Nature,
603(7900), 309-314.
https://doi.org/10.1038/s41586-022-04461-2Pan, X., Qu, K., Yuan, H.
, Xiang, X., Anthon, C., Pashkova, L., Liang, X., Han, P., Corsi, G. I., Xu, F., Liu, P., Zhong, J.
, Zhou, Y., Ma, T., Jiang, H., Liu, J., Wang, J.
, Jessen, N., Bolund, L. ... Luo, Y. (2022).
Massively targeted evaluation of therapeutic CRISPR off-targets in cells.
Nature Communications,
13(1), Article 4049.
https://doi.org/10.1038/s41467-022-31543-6Paternoster, V., Cömert, C., Kirk, L. S., la Cour, S. H., Fryland, T., Fernandez-Guerra, P., Stougaard, M., Nyengaard, J. R., Qvist, P., Bross, P., Børglum, A. D. & Christensen, J. H. (2022).
The psychiatric risk gene BRD1 modulates mitochondrial bioenergetics by transcriptional regulation.
Translational Psychiatry,
12(1), Article 319.
https://doi.org/10.1038/s41398-022-02053-2
Pedersen, E. M., Agerbo, E., Plana-Ripoll, O., Grove, J., Dreier, J. W., Musliner, K. L., Bækvad-Hansen, M., Athanasiadis, G., Schork, A., Bybjerg-Grauholm, J., Hougaard, D. M., Werge, T., Nordentoft, M.
, Mors, O., Dalsgaard, S., Christensen, J., Børglum, A. D., Mortensen, P. B., McGrath, J. J. ... Vilhjálmsson, B. J. (2022).
Accounting for age of onset and family history improves power in genome-wide association studies.
American Journal of Human Genetics,
109(3), 417-432.
https://doi.org/10.1016/j.ajhg.2022.01.009
Pedersen, S., Jensen, K. P.
, Honoré, B., Kristensen, S. R., Pedersen, C. H., Szejniuk, W. M., Maltesen, R. G. & Falkmer, U. (2022).
Circulating microvesicles and exosomes in small cell lung cancer by quantitative proteomics.
Clinical Proteomics,
19, Article 2.
https://doi.org/10.1186/s12014-021-09339-5
Pedersen, J. G., Sokac, M., Sørensen, B. S., Luczak, A. A.
, Aggerholm-Pedersen, N., Birkbak, N. J., Øllegaard, T. H. & Jakobsen, M. R. (2022).
Increased Soluble PD-1 Predicts Response to Nivolumab plus Ipilimumab in Melanoma.
Cancers,
14(14), Article 3342.
https://doi.org/10.3390/cancers14143342
Pedersen, A. K. N., Hage, C.
, Jessen, N., Mellbin, L.
& Bjerre, M. (2022).
Sitagliptin reduces FAP-activity and increases intact FGF21 levels in patients with newly detected glucose abnormalities.
Molecular and Cellular Endocrinology,
556, Article 111738.
https://doi.org/10.1016/j.mce.2022.111738